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Chairman: Sir John McMichael, F.R.S. 
 
Abstract 
Professor Donald: The speakers have mentioned a number of factors, blood pressure, obesity and so on, but neither of them mentioned the question of family incidence of this disease which some of us hope, with good family histories might be favourable.  
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THIRD DISCUSSION
Chairman: Sir John McMichael, F.R.S. Olim Scriba
Professor Donald: T h e speakers have mentioned a 
num ber o f factors, blood pressure, obesity and so 
on, but neither o f them mentioned the question of 
fam ily incidence o f this disease which some o f us 
hope, with good fam ily histories might be favour­
able.
Dr. Robertson: I wonder i f  Professor M orris or 
Dr. O liver has correlated the number o f miles 
driven in motor cars to the incidence o f coronary 
heart disease, and particularly driving in traffic as 
opposed to driving on the open ro ad ; after all, the 
incidence o f this modern epidemic roughly corre- 
lates to the rise o f the motor car. I was very 
interested in a recent article which described a 
test in which a cardiotachometer was attached to 
the driver o f a motor car and whilst waiting at the 
lights a pulse o f 150-200 was recorded; this was 
quite usual.
Professor Hunter: I would like to ask Dr. O liver 
i f  it is a reasonable risk to give Atrom id-S for 5 
years to otherwise healthy people?
Dr. Borchgrevinck (Oslo): Dr. Oliver, do you sug­
gest that there m ay be a difference in response to 
what you call two different cultures, and do you 
think it might confuse the issue by bringing them 
into the study and possibly finding that the posi­
tive effects o f the treatment in Britain, for in­
stance, might differ from the results achieved effect 
in the other countries?
Dr. Turner: W ould Professor M orris care to 
comment on the recent criticisms that have been 
made on the London Hospital pathological 
studies ? I know most o f you will be fam iliar with 
the work on the exceptionally good pathological 
m aterial which apparently shows that the inci­
dence o f atherosclerosis has not changed very 
much and is certainly not commensurate with the 
apparent increase in coronary thrombosis. Dr. 
Robert Smith has recently published a book 
criticising this; he questioned whether there had 
in fact been this rem arkable increase in clinical
coronary artery disease on the grounds that 
insufficient attention had been paid to the chang­
ing age population in the London Hospital patho­
logical m aterial; this is obviously o f very great 
importance.
Professor Morris: Recent studies have confirmed 
that the fam ily history is important. In two main 
studies, one o f whole populations and another 
based in London, findings suggest that the chance 
o f a person developing a coronary is strikingly 
higher where there is a fam ily history o f the 
disease. T hey haven’t taken it any further yet in 
terms o f explaining the mechanism because inso­
far as we know blood pressure, cholesterol levels 
and obesity are all important mechanisms in 
disease; so the genetic components o f these 
do not begin to explain the very striking fam ily 
history. In answering the question which Dr. 
Robertson put, I would say that it is a question of 
whether it is the sitting and driving or whether it 
is the nervous strain. We don’ t know, but per­
haps the answers will come from monitoring as 
you suggest. Professor Hunter asked whether we 
think it is a reasonable risk to give Atrom id-S to 
people over a long period o f time. Yes. We have 
looked at this very carefully, Atrom id-S has been 
studied as you know for at least 6 years and some 
5,000 men in this country have been receiving 
the drug for 2 years or m ore; one case o f agranulo­
cytosis has been reported in a patient who was 
also receiving three other drugs, one o f which was 
known to produce agranulocytosis before, and 
which occurred at a stage when maturation 
arrest would not be expected, that is to say, three 
days after the administration o f Atrom id-S. It 
appears to be non-toxic and it has no side effects 
so far as we can see other than that which one 
would expect from oil. We are rather impressed 
by the effects o f the drug. There is a system within 
our survey which will show difficulties as they 
rise; if  toxicity or if  serious side effects occur they
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will become rapidly evident and will stop the trial.
Dr. Borchgrevinck: M ight the application of the 
study in the two cultures confuse us? I t  could, bu t 
I think it is desirable tha t we should do it because 
it seems to me very im portant tha t if our study 
cannot be replicated in another culture then it is 
less meaningful and  surely if  we can reproduce the 
same results in o ther cultures they are likely to be 
more widely accepted.
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